Antiangiogenic cancer therapy: monitoring with molecular US and a clinically translatable contrast agent (BR55). (Q30474689)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Antiangiogenic cancer therapy: monitoring with molecular US and a clinically translatable contrast agent (BR55). |
scientific article |
Statements
1 reference
Antiangiogenic cancer therapy: monitoring with molecular US and a clinically translatable contrast agent (BR55). (English)
1 reference
1 reference
Marybeth A Pysz
1 reference
Kira Foygel
1 reference
Jarrett Rosenberg
1 reference
Sanjiv S Gambhir
1 reference
Michel Schneider
1 reference
1 June 2010
1 reference
1 reference
519-527
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference